|
業務類別
|
Medical Devices |
|
業務概覽
|
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-usedevices and related services used in patient treatments. |
| 公司地址
| 2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5 |
| 電話號碼
| +1 647 476-1350 |
| 傳真號碼
| +1 647 847-3739 |
| 公司網頁
| https://www.profoundmedical.com |
| 員工數量
| 162 |
| Mr. Tom Tamberrino |
Chief Commercial Officer |
美元 66.46K |
05/03/2026 |
| Dr. Mathieu Burtnyk |
President |
美元 252.00K |
05/03/2026 |
| Mr. Rashed Dewan |
Chief Financial Officer and Principal Acounting Officer |
美元 252.00K |
05/03/2026 |
| Dr. Arun Menawat,PhD |
Chief Executive Officer and Chairman of the Board |
美元 514.44K |
05/03/2026 |
|
|
| Dr. Cynthia Lavoie |
Independent Director |
05/03/2026 |
| Mr. Brian Ellacott |
Lead Independent Director |
05/03/2026 |
| Ms. Murielle Lortie |
Independent Director |
05/03/2026 |
| Dr. Arun Menawat,PhD |
Chief Executive Officer and Chairman of the Board |
05/03/2026 |
| Dr. Arthur L Rosenthal |
Independent Director |
05/03/2026 |
| Mr. Frank Baylis |
Director |
10/03/2026 |
|
|
|
|
